CELLDEX

Welcome to the Brand page for “CELLDEX”, which is offered here for Vaccines; therapeutic vaccines; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for immunotherapy treatment; antibody drug conjugates, pharmaceutical preparations for the treatment of cancer, and for the treatment of diseases of the integumentary system and reproductive system; pharmaceutical preparations derived from monoclonal antibodies for the treatment of cancer, and for the treatment of diseases of the respiratory system, circulatory system, lymphatic system, nervous system, urinary system, digestive system, integumentary system and reproductive system; therapeutic antibodies and immune system modulators, pharmaceutical preparations for the treatment of cancer, and for the treatment of diseases of the respiratory system, circulatory system, lymphatic system, nervous system, urinary system, digestive system, integumentary system and reproductive system; pharmaceutical preparations and substances for use as vaccine adjuvants, growth factors, ligands and proteins for stem cells in stem cell mobilization; pharmaceutical preparations for the treatment of immune system related diseases and disorders, immune system stimulators and immune system modulators;.

Its status is currently believed to be active. Its class is unavailable. “CELLDEX” is believed to be currently owned by “CELLDEX THERAPEUTICS, INC.”